These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8011711)

  • 21. Seroprevalence survey of borreliosis in children with chronic arthritis in British Columbia, Canada.
    Banerjee S; Banerjee M; Cimolai N; Malleson P; Proctor E
    J Rheumatol; 1992 Oct; 19(10):1620-4. PubMed ID: 1464879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The epidemiological aspects of Lyme borreliosis in Sverdlovsk Province].
    Lesniak OM; Ponomarev DN; Volkova LI; Il'ina NS; Laĭkovskaia EE; Dvoskina BIa
    Med Parazitol (Mosk); 1995; (1):7-10. PubMed ID: 7770026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinuclear antibodies are not increased in the early phase of Borrelia infection.
    Spiewak R; Stojek NM; Chmielewska-Badora J
    Ann Agric Environ Med; 2004; 11(1):145-8. PubMed ID: 15236512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinico-serological study of Lyme disease in the northwestern USSR].
    Anan'eva LP; Korenberg EI; Skripnikova IA; Soldatkina LM; Nasonova VA
    Med Parazitol (Mosk); 1990; (6):28-31. PubMed ID: 2290396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of Borrelia burgdorferi antibodies in a population sample of the state of Zulia].
    Arocha-Sandoval F; Amesty-Valbuena A; Urbina M; Durango AI; Vargas-Montiel H
    Invest Clin; 1994 Jun; 35(2):91-104. PubMed ID: 7918761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Informational value of the prevalence of antiborrelia antibodies in a healthy and at risk population].
    Bartůnĕk P; Mrázek V; Varejka P; Sklenár T; Bína R; Listvanová S; Janovská D
    Epidemiol Mikrobiol Imunol; 2000 Feb; 49(1):4-10. PubMed ID: 10802944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The experience of a serological examination of the rural population in a territory endemic for Lyme borreliosis].
    Korenberg EI; Kalinin MI; Skripnikova IA; Soldatkina LM
    Med Parazitol (Mosk); 1990; (3):15-6. PubMed ID: 2145501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of antibodies to Borrelia burgdorferi, Borrelia parkeri and Borrelia turicatae in human settlements of the Cordillera Province, Bolivia.
    Ciceroni L; Bartoloni A; Guglielmetti P; Paradisi F; Barahona HG; Roselli M; Ciarrocchi S; Cacciapuoti B
    J Trop Med Hyg; 1994 Feb; 97(1):13-7. PubMed ID: 8107167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of Borrelia burgdorferi seropositivity in an area endemic for Lyme disease.
    Jochimsen E; Sikkink J; Marx JJ
    Wis Med J; 1990 Dec; 89(12):677-81. PubMed ID: 2293487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroepidemiologic study on Lyme borreliosis in the Lublin region.
    Chmielewska-Badora J
    Ann Agric Environ Med; 1998; 5(2):183-6. PubMed ID: 9860821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological evidence of Lyme borreliosis in Africa: results from studies in Dar es Salaam, Tanzania.
    Mhalu FS; Matre R
    East Afr Med J; 1996 Sep; 73(9):583-5. PubMed ID: 8991238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and prevalence of seropositivity against Borrelia burgdorferi antigen in La Rioja, Spain.
    Oteo JA; Martinez de Artola V; Casas J; Lozano A; Fernandez Calvo JL; Grandival R
    Rev Epidemiol Sante Publique; 1992; 40(2):85-92. PubMed ID: 1631381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibodies against Borrelia afzelli in patients with an early stage of Lyme disease].
    Flisiak I; Chodynicka B
    Wiad Lek; 2001; 54(1-2):19-25. PubMed ID: 11344697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of tick-borne bacterial diseases among workers of Roztocze National Park (south-eastern Poland).
    Cisak E; Chmielewska-Badora J; Zwoliński J; Wójcik-Fatla A; Polak J; Dutkiewicz J
    Ann Agric Environ Med; 2005; 12(1):127-32. PubMed ID: 16028877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of Lyme borreliosis in a Swiss population at risk].
    Fahrer H; Sauvain MJ; vd Linden S; Zhioua E; Gern L; Aeschlimann A
    Schweiz Med Wochenschr; 1988 Jan; 118(2):65-9. PubMed ID: 3344410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lyme disease in Chile. Prevalence study in selected groups].
    Neira O; Cerda C; Alvarado MA; Palma S; Abumohor P; Wainstein E; Guzmán L; Juliet C; Pérez C; Raggio X; Rojas I; Honorato H; Alcaíno H; Fredes F
    Rev Med Chil; 1996 May; 124(5):537-44. PubMed ID: 9035504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Localized scleroderma (morphea) and septic arthritis. Clinical manifestations of Lyme borreliosis seen in El Ferrol].
    Maestre JR; Almagro M; Martínez P; de Casas R; Quesada R; Egido J
    Enferm Infecc Microbiol Clin; 1991; 9(7):394-8. PubMed ID: 1799607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from midwestern Germany.
    Hunfeld KP; Allwinn R; Peters S; Kraiczy P; Brade V
    Wien Klin Wochenschr; 1998 Dec; 110(24):901-8. PubMed ID: 10048174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.